Lisata Therapeutics, Inc.LSTANASDAQ
Loading
Year-over-year SG&A expense growth
Percentile
P15
Within normal range
vs 5Y Ago
-1.8x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -16.70% |
| Q3 2025 | -8.57% |
| Q2 2025 | -17.26% |
| Q1 2025 | 8.20% |
| Q4 2024 | 7.34% |
| Q3 2024 | -4.38% |
| Q2 2024 | -13.04% |
| Q1 2024 | 11.55% |
| Q4 2023 | 16.56% |
| Q3 2023 | -30.41% |
| Q2 2023 | 1.31% |
| Q1 2023 | 8.72% |
| Q4 2022 | -15.56% |
| Q3 2022 | 14.52% |
| Q2 2022 | 4.47% |
| Q1 2022 | 23.64% |
| Q4 2021 | -5.07% |
| Q3 2021 | 0.89% |
| Q2 2021 | -6.38% |
| Q1 2021 | 18.55% |
| Q4 2020 | 9.39% |
| Q3 2020 | -6.18% |
| Q2 2020 | -3.28% |
| Q1 2020 | 10.50% |
| Q4 2019 | 11.94% |
| Q3 2019 | -12.30% |
| Q2 2019 | -7.67% |
| Q1 2019 | 11.63% |
| Q4 2018 | 10.96% |
| Q3 2018 | -3.96% |
| Q2 2018 | -25.86% |
| Q1 2018 | 8.55% |
| Q4 2017 | -9.34% |
| Q3 2017 | -14.27% |
| Q2 2017 | 26.85% |
| Q1 2017 | 18.23% |
| Q4 2016 | -17.33% |
| Q3 2016 | -41.16% |
| Q2 2016 | -27.13% |
| Q1 2016 | 28.29% |